20
Participants
Start Date
May 3, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Lipopolysaccharide (LPS)
Lipopolysaccharide (LPS), single i.v. bolus, 0.4 ng/kg body weight
Placebo
Normal saline, single i.v. bolus, in equal volume to intervention
RECRUITING
UZ/KU Leuven, Leuven
Universitaire Ziekenhuizen KU Leuven
OTHER